{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T17:25:57Z","timestamp":1747675557061,"version":"3.37.3"},"reference-count":17,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004561","name":"Ministry of Education and Science of the Republic of Kazakhstan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.072","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T17:07:16Z","timestamp":1473440836000},"page":"5049-5052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Kaissar","family":"Tabynov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukhit","family":"Orynbayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gourapura J.","family":"Renukaradhya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abylai","family":"Sansyzbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.072_b0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1051\/vetres:2005003","article-title":"From the discovery of the Malta fever\u2019s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis","volume":"36","author":"Godfroid","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2016.08.072_b0010","first-page":"101","article-title":"Safety of the novel vector vaccine against Brucella abortus based on recombinant influenza viruses expressing Brucella L7\/L12 and OMP16 proteins, in cattle","volume":"1","author":"Tabynov","year":"2014","journal-title":"J Vacc Immun"},{"key":"10.1016\/j.vaccine.2016.08.072_b0015","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2014.02.058","article-title":"Novel influenza virus vectors expressing Brucella L7\/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.072_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1590\/0103-8478cr20150497","article-title":"Safety of the novel influenza viral vector Brucella abortus vaccine in pregnant heifers","volume":"46","author":"Tabynov","year":"2016","journal-title":"Cienc Rural"},{"key":"10.1016\/j.vaccine.2016.08.072_b0025","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1016\/j.vaccine.2014.08.073","article-title":"Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7\/L12 or Omp16 proteins: evaluation of protection in pregnant heifers","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.072_b0030","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1586\/14760584.4.6.915","article-title":"Essential role of vaccines in brucellosis control and eradication programs for livestock","volume":"4","author":"Olsen","year":"2005","journal-title":"Exp Rev Vacc"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.08.072_b0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1751-0147-45-211","article-title":"A serological survey of ruminant livestock in Kazakhstan during post-Soviet transitions in farming and disease control","volume":"45","author":"Lundervold","year":"2004","journal-title":"Acta Vet Scand"},{"key":"10.1016\/j.vaccine.2016.08.072_b0040","unstructured":"Ivanov NP. Brucellosis in animals and its control measures. 2nd ed., corr., ext. Almaty; 2007 [in Russian]."},{"key":"10.1016\/j.vaccine.2016.08.072_b0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.072_b0050","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2004.02.041","article-title":"Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51","volume":"22","author":"Ashford","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.072_b0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-11-69","article-title":"Influenza viral vectors expressing the Brucella OMP16 or L7\/L12 proteins as vaccines against B. abortus infection","volume":"11","author":"Tabynov","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.08.072_b0060","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.vaccine.2015.12.028","article-title":"Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection","volume":"34","author":"Tabynov","year":"2016","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2016.08.072_b0065","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.vaccine.2015.06.045","article-title":"An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers","volume":"33","author":"Tabynov","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.072_b0070","first-page":"19","article-title":"Brucella abortus vaccine strain RB51: a brief review","volume":"27","author":"Schurig","year":"1995","journal-title":"Arch Med Vet"},{"key":"10.1016\/j.vaccine.2016.08.072_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.08.072_b0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1469-7580.2005.00394.x","article-title":"The role of eye-associated lymphoid tissue in corneal immune protection","volume":"206","author":"Knop","year":"2005","journal-title":"J Anat"},{"key":"10.1016\/j.vaccine.2016.08.072_b0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000219678","article-title":"Conjunctiva-associated lymphoid tissue \u2013 current knowl-edge, animal models and experimental prospects","volume":"42","author":"Steven","year":"2009","journal-title":"Ophthal Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630768X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630768X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T23:12:33Z","timestamp":1656285153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630768X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":17,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X1630768X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}